Metabolism
Showing 9976 - 10000 of >10,000
Pulmonary Disease, Chronic Obstructive Trial in Poland, Russian Federation, United States (FF/UMEC/VI, Tiotropium,
Completed
- Pulmonary Disease, Chronic Obstructive
- FF/UMEC/VI
- +7 more
-
Andalusia, Alabama
- +71 more
Jul 13, 2021
Hematologic Malignancies, Hypoproliferative Thrombocytopenia Trial in United States (Mirasol platelets (MIR PLTs), Reference
Terminated
- Hematologic Malignancies
- Hypoproliferative Thrombocytopenia
- Mirasol platelets (MIR PLTs)
- Reference platelets (REF PLTs)
-
Washington, District of Columbia
- +9 more
Jul 28, 2021
Aging Trial in Baton Rouge (Physical Activity, Successful Aging)
Completed
- Aging
- Physical Activity
- Successful Aging
-
Baton Rouge, LouisianaPennington Biomedical Research Center
Jun 23, 2020
Behavior Trial (Behavioral interventions/modifications)
Withdrawn
- Behavior
- Behavioral interventions/modifications
- (no location specified)
Jun 22, 2020
Mild Cognitive Impairment, Alzheimer Dementia Trial in Cadiz (Supervised Exercise Programme)
Completed
- Mild Cognitive Impairment
- Alzheimer Dementia
- Supervised Exercise Programme
-
Cadiz, SpainUniversity of Cádiz
Apr 26, 2021
NSCLC Trial in United States (enzastaurin, pemetrexed, docetaxel)
Completed
- Non-Small Cell Lung Cancer
- enzastaurin
- +3 more
-
Burlington, North Carolina
- +3 more
Apr 20, 2021
Non Small Cell Lung Cancer, ROS1 Proto Oncogene, Crizotinib Trial in Worldwide (Crizotinib)
Completed
- Non Small Cell Lung Cancer
- +2 more
-
Hefei, Anhui, China
- +43 more
Feb 3, 2021
Friedreich Ataxia Trial in Paris (EGb 761 120 mg, Placebo)
Completed
- Friedreich Ataxia
- EGb 761 120 mg
- Placebo
-
Paris, FranceHospital Necker Enfants Malades
Mar 30, 2020
Obesity Trial (G-Niib, Placebo)
Not yet recruiting
- Obesity
- G-Niib
- Placebo
- (no location specified)
Aug 10, 2021
Diabetes Mellitus for Presence of Skin Disorder of Scleredema
Recruiting
- Diabetes Mellitus
- +3 more
-
Pécs, Baranya, HungaryDept. Rheumatology and Immunology, University of Pécs
Apr 6, 2020
Choriocarcinoma, FIGO Stage I GTD, FIGO Stage II GTD Trial in Worldwide (biological, drug, other)
Completed
- Choriocarcinoma
- +4 more
- Dactinomycin
- +3 more
-
Anchorage, Alaska
- +288 more
Aug 10, 2022
Melanoma Trial in Worldwide (Talimogene Laherparepvec, Pembrolizumab, Placebo)
Terminated
- Melanoma
- Talimogene Laherparepvec
- +2 more
-
Birmingham, Alabama
- +160 more
Nov 10, 2022
Major Depression Trial in United States (Pharmacogenetic Test)
Completed
- Major Depression
- Pharmacogenetic Test
-
North Little Rock, Arkansas
- +23 more
Apr 13, 2022
Iron Deficiency Anemia Secondary to IBD or Gastric Bypass Trial (Injectafer, Ferrous Sulfate tablets)
Completed
- Iron Deficiency Anemia Secondary to IBD or Gastric Bypass
- Injectafer
- Ferrous Sulfate tablets
- (no location specified)
Sep 16, 2020
Juvenile Idiopathic Arthritis Trial in Worldwide (Baricitinib, Placebo)
Completed
- Juvenile Idiopathic Arthritis
- Baricitinib
- Placebo
-
Rosario, Santa Fe, Argentina
- +85 more
Sep 8, 2022
Peripheral Arterial Diseases Trial in Georgia, Kazakhstan, Russian Federation (Actovegin, Placebo)
Herpes Simplex Type 2 Trial in Portland, Houston, Seattle (HerpV and QS-21, Placebo)
Completed
- Herpes Simplex Type 2
- HerpV and QS-21
- Placebo
-
Portland, Oregon
- +4 more
Jun 22, 2021
Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)
Completed
- Chronic Hepatitis C
- +2 more
- (no location specified)
Jul 9, 2021
Carcinoma, Renal Cell Trial in Worldwide (Regorafenib (Stivarga, BAY73-4506))
Completed
- Carcinoma, Renal Cell
- Regorafenib (Stivarga, BAY73-4506)
-
Los Angeles, California
- +17 more
Jan 27, 2021
SLC13A5 Deficiency Natural History Study - Remote Only
Recruiting
- Citrate Transporter Deficiency
- +9 more
-
Palo Alto, CaliforniaLucille Packard Children's Hospital, Stanford University
Dec 22, 2020